2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile, 95.0%, 25g

Methyl 6-phenylpyrazine-2-carboxylate, 95.0%, 1g

4-Bromo-4'-chlorobenzhydrol, 97.0%, 1g

Olmutinib, 90%, 50mg

Flat flange reaction vessel cylindrical, graduated (2) Flat bottom, DN 100, 160 mm, Height, 300 mm, 1 Piece

GC capillary column ROTI®Cap-5 MS, 50 m, 0.20 mm, 0.35 µm, 1 Piece(s)

5-bromo-6-fluoro-1-methyl-1H-indazole, 97.0%, 250mg

2-Chloro-n-(1-cyanocyclohexyl)-n-methylacetamide, 97%, 250mg

2-(4-((3-Chlorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

trans-4-Bromocinnamaldehyde>98.0%(GC)1g

5-Chlorobenzo[b]thiophene-3-ethanamine, 95%, 100mg

(2-(Benzyloxy)-3-bromo-5-methylphenyl)boronic acid, 95.0%, 1g

4-Fluoro-7-nitro-indoline, 98%, 250mg